BriaCell presents positive clinical data in three posters at the San Antonio Breast Cancer Symposium (SABCS®) Phase 3 study ...

Dubai Health successfully convened the second edition of the Dubai Health Research Conference 2025. The event brought together physicians, experts, and academics to present the latest in medical ...

Tempus AI, Inc. (NASDAQ: TEM), a technology company leading the adoption of AI to advance precision medicine, today announced that ten abstracts have been accepted for presentation at the 2025 San ...

The Muscular Dystrophy Association (MDA) announced today that John F. Crowley, President and CEO of the Biotechnology Innovation Organization (BIO), will deliver the keynote address at the 2026 MDA ...

Lee University natural science students, Alexa VanVeghten and Karina Dilse, presented research posters at the 2025 Tennessee ...

Frankel, a former research fellow at Harvard, said she wrote the book — a collection of her photographs of nature and scientific explanations of the scenes — to help young people understand science.

"Our significant showcase at ASH this year reflects Parexel’s specialized scientific and medical expertise in hematology and our commitment to partnering with leading biopharma sponsors to advance ...

At the 2025 North American Conference on Lung Cancer (NACLC), December 5 - 7, in Chicago, IL, Biodesix will present new findings on its on-market Nodify Lung ® tests, with data that spotlight the ...

Students in the WWAMI Medical Education Program at the University of Wyoming recently presented their summer research ...

SK Life Science, Inc., a global leader in treatments for central nervous system (CNS) disorders and a subsidiary of SK Biopharmaceuticals Co., Ltd., will present new data on cenobamate, an ...

Nearly eight months after Kanzi, the celebrated bonobo at Des Moines’ Ape Cognition and Conservation Initiative, died more than 150 people came together to honor his life and legacy. The gathering, ...

CAMBRIDGE, Mass., Nov. 03, 2025 (GLOBE NEWSWIRE) -- Editas Medicine, Inc. (EDIT), a pioneering gene editing company focused on developing transformative medicines for serious diseases, today announced ...